Early studies showed that both MMP-2 (gelatinase-A) and MMP-9 (gelatinase-B) can cleave Gal-3 at specific residues within its N-terminal tail (Ala62-Tyr63), leading to reduced cell surface expression in human breast cancer cell lines (161). Here, MMP2 is linked to breast carcinoma.